Taken together, these observations indicate that the impact of m6A on tumor immunogenicity hinges less on overall mark abundance than on which reader or transcript lies downstream (e.g., YTHDF1–lysosome versus YTHDF2–NLRC5) (101, 102). The gene discussed is YTHDF2; the disease is neoplasm.